Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001273091-21-000005
Filing Date
2021-05-10
Accepted
2021-05-10 16:08:27
Documents
1
Group Members
ISRAEL A. ENGLANDERMILLENNIUM GROUP MANAGEMENT LLCMILLENNIUM MANAGEMENT LLCRIVERVIEW GROUP LLC

Document Format Files

Seq Description Document Type Size
1 RACA_SC13G.htm SC 13G 95249
  Complete submission text file 0001273091-21-000005.txt   97034
Mailing Address 399 PARK AVENUE NEW YORK NY 10022
Business Address 399 PARK AVENUE NEW YORK NY 10022 (212) 841-4100
RIVERVIEW GROUP LLC (Filed by) CIK: 0001273091 (see all company filings)

EIN.: 980330397 | Fiscal Year End: 1231
Type: SC 13G

Mailing Address 200 BERKELEY STREET 18TH FLOOR BOSTON MA 02116
Business Address 200 BERKELEY STREET 18TH FLOOR BOSTON MA 02116 617-778-2500
Therapeutics Acquisition Corp. (Subject) CIK: 0001811764 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-91575 | Film No.: 21907212
SIC: 2834 Pharmaceutical Preparations